- Research works
- 1 ▼ 100% vs 2013–17
- Citations
- 35 29.2 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 83% world 28%
Not ranked overall: RestorGenex (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does RestorGenex (United States) publish most on?
By volume: Cancer Mechanisms and Therapy, PI3K/AKT/mTOR signaling in cancer, CRISPR and Genetic Engineering and Cancer Treatment and Pharmacology.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Mechanisms and Therapy Pathology and Forensic Medicine 0 works
- 2 PI3K/AKT/mTOR signaling in cancer Molecular Biology 0 works
- 3 CRISPR and Genetic Engineering Molecular Biology 0 works
- 4 Cancer Treatment and Pharmacology Oncology 0 works
- 5 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
Other research institutions in Buffalo Grove
- BrightOutcome (United States)
- Cured Foundation
- The Ream Foundation
- The Foundation for Peripheral Neuropathy
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.